Cue Biopharma, Inc. (CUE)
19.95
+0.53
(+2.73%)
USD |
NASDAQ |
Nov 03, 13:31
Cue Biopharma Price to Book Value : 45.16 for Nov. 3, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 43.96 |
| October 30, 2026 | 47.25 |
| October 29, 2026 | 48.56 |
| October 28, 2026 | 47.90 |
| October 27, 2026 | 41.47 |
| October 26, 2026 | 41.77 |
| October 23, 2026 | 42.24 |
| October 22, 2026 | 42.76 |
| October 21, 2026 | 42.90 |
| October 20, 2026 | 38.58 |
| October 19, 2026 | 36.40 |
| October 16, 2026 | 37.83 |
| October 15, 2026 | 42.27 |
| October 14, 2026 | 42.11 |
| October 13, 2026 | 44.30 |
| October 12, 2026 | 55.71 |
| October 09, 2026 | 62.62 |
| October 08, 2026 | 50.55 |
| October 07, 2026 | 50.96 |
| October 06, 2026 | 52.38 |
| October 05, 2026 | 55.15 |
| October 02, 2026 | 57.89 |
| October 01, 2026 | 57.16 |
| September 30, 2026 | 58.56 |
| September 29, 2026 | 57.75 |
| Date | Value |
|---|---|
| September 28, 2026 | 62.14 |
| September 25, 2026 | 71.11 |
| September 24, 2026 | 74.37 |
| September 23, 2026 | 71.79 |
| September 22, 2026 | 69.95 |
| September 21, 2026 | 64.00 |
| September 18, 2026 | 83.87 |
| September 17, 2026 | 85.66 |
| September 16, 2026 | 77.35 |
| September 15, 2026 | 71.63 |
| September 14, 2026 | 69.16 |
| September 11, 2026 | 65.06 |
| September 10, 2026 | 63.39 |
| September 09, 2026 | 69.05 |
| September 08, 2026 | 67.91 |
| September 04, 2026 | 62.12 |
| September 03, 2026 | 62.64 |
| September 02, 2026 | 61.03 |
| September 01, 2026 | 64.38 |
| August 31, 2026 | 57.77 |
| August 28, 2026 | 63.12 |
| August 27, 2026 | 63.75 |
| August 26, 2026 | 65.31 |
| August 25, 2026 | 60.58 |
| August 24, 2026 | 52.48 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cypherpunk Technologies, Inc. | 1.996 |
| Yarrow Bioscience, Inc. | 0.5243 |
| Faeth Therapeutics, Inc. | 2.966 |
| Indaptus Therapeutics, Inc. | 38.31 |
| Pyxis Oncology, Inc. | 9.177 |
Price to Book Value Related Metrics
| PS Ratio | 2.410 |
| PEG Ratio | -0.0025 |
| Price | 19.95 |
| Earnings Yield | -135.3% |
| Market Cap | 104.33M |
| PEGY Ratio | -0.0025 |